A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
Clinical trial NCT03339453 · COMPLETED
Trial details
- NCT number
- NCT03339453
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2017-12-17
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.